The China chief of AstraZeneca - Britain's biggest company - was arrested months ago, but his condition and whereabouts ...

Doctors with special licenses no longer need to use special prescription pads that are difficult to obtain for their patients ...

The company has invoked the murder of an executive last year to complain about coverage in news outlets, on streaming ...

Welcome to our live blog covering the latest from Europe. Track major updates on EU politics, NATO dynamics, energy ...

Boy, I know that there are some really terrible jobs in the extended health care universe, but it sure seems like one of them ...

Markets reflect a widespread belief that the US president always chickens out on trade measures. AstraZeneca’s plan to invest ...

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...

Troubled by unregulated access by pharmaceutical representatives, Ram Manohar Lohia (RML) Hospital has banned the entry of ...

In other recent news, Merck is nearing the acquisition of Verona Pharma in a deal valued at approximately $10 billion, with the pharmaceutical giant set to pay $107 per American Depositary Share.

Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...

Roche (RHHBY) plans direct-to-patient drug sales in the U.S. to avoid the influence from pharmacy benefit managers in product ...

See disclosure here or remove ads. In other recent news, Phio Pharmaceuticals Corp. reported encouraging developments in its Phase 1b clinical trial of PH-762, a treatment for skin cancer.